Targeting physical health in schizophrenia: Results from the Physical Activity Can Enhance Life (PACE-Life) 24-week open trial. (March 2021)

• Record Type: Journal Article
• Authors: Browne, Julia; Battaglini, Claudio; Jarskog, L. Fredrik; Sheeran, Paschal; Abrantes, Ana M.; McDermott, Jessica; Elliott, Tonya; Gonzalez, Oscar; Penn, David L.
• Is Part Of: Mental health and physical activity. Volume 20(2021)
• Publication Date: 2021-03
• Subjects: Exercise -- Serious mental illness -- Motivation -- Cardiorespiratory Fitness -- Psychosis -- Walking; Mental illness -- Prevention -- Periodicals; Exercise -- Psychological aspects -- Periodicals; Depression, Mental -- Exercise therapy -- Periodicals; Anxiety -- Exercise therapy -- Periodicals; 616.89
• DOI: 10.1016/j.mhpa.2021.100393
• Languages: English
• ISSNs: 1755-2966

Abstract

Abstract: Poor health and low cardiorespiratory fitness (CRF) contribute substantially to the shortened lifespan of individuals with schizophrenia spectrum disorders (SSDs). Increasing physical activity has demonstrated value; however, there are limited interventions that are accessible and adequately address motivational challenges. This paper reports on an open trial of Physical Activity Can Enhance Life (PACE-Life), a motivational theory-based manualized multicomponent walking intervention. The primary aim was to examine the feasibility of implementing PACE-Life through meeting the recruitment target (n = 14), attendance and adherence rates, and participant feedback. The secondary aim was to assess the impact of PACE-Life on intermediate targets (autonomous motivation and satisfaction of autonomy, relatedness, and competence needs), proximal outcomes (Fitbit steps/day and minutes spent walking), the primary outcome (CRF), and secondary outcomes (loneliness, symptoms, resting heart rate, blood pressure, weight, body mass index, and hip and waist circumference). Seventeen participants with SSDs enrolled in a 24-week open trial. Assessments occurred at baseline, mid-point, post-test, and one-month follow-up. The recruitment target was exceeded, the group attendance rate was 34%, Fitbit adherence rate was 54%, and participant feedback indicated satisfaction with the intervention as well as a positive group environment. There was a large improvement in the primary outcome of CRF with 77% of participants achieving clinically significant improvement at post-test. Small and medium effect size increases were observed in autonomous motivation and satisfaction of autonomy, relatedness, and competence needs. Fitbit data and secondary outcomes generally remained unchanged or worsened during the intervention. Results from this open trial indicate that PACE-Life leads to meaningful changes in CRF among people with SSDs. Highlights: PACE-Life is a theory-based walking intervention for persons with schizophrenia. There was a large improvement in cardiorespiratory fitness from baseline to post-test. 77% achieved clinically significant improvement in cardiorespiratory fitness. There were increases in motivation and satisfaction of basic psychological needs.